News

This decision follows a recent pre-biologics license application (BLA) meeting in which the company reviewed safety and efficacy data with the FDA from its two completed phase III

This pivotal clinical trial is intended to support a new drug application for the management of chronic lower back pain. The randomized trial will recruit approximately 600 outpatients

The generic versions of the drug will now compete in a market place where, according to NDCHealth, US sales of Glucophage XR 750mg were approximately $23 million in

Funding from the agency, which is part of the US Department of Health and Human Services, will be released in stages contingent upon the achievement of developmental milestones.

The study met its primary endpoint of non-inferiority to carbamazepine, an epilepsy drug produced by Novartis under the name Tegretol. The trial compared Keppra (levetiracetam) to sustained release

Health Canada has approved Erbitux (cetuximab) injection for use in combination with irinotecan in the treatment of patients with epidermal growth factor receptor expressing, metastatic colorectal cancer who

The biotech company’s sterile patch contains a concentration of sustained-release lidocaine. Under the protocol, investigators apply the patch directly over the incision upon closing and leave the patch

Understanding the function of the protien could shed light on disease states involving inappropriate cell movement, such as cancer metastasis. The scientists at Boston Biomedical combined several techniques

According to the analysis by Medco Health Solutions, the number of younger adults aged 20-44 using ADHD medications more than doubled from 2000 to 2004, outpacing increases in